
[Federal Register Volume 82, Number 171 (Wednesday, September 6, 2017)]
[Notices]
[Page 42098]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18813]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-4642]


B. Braun Medical, Inc.; Withdrawal of Approval of Three New Drug 
Applications and One Abbreviated New Drug Application; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a 
document entitled ``B. Braun Medical, Inc.; Withdrawal of Approval of 
Three New Drug Applications and One Abbreviated New Drug Application'' 
that appeared in the Federal Register of August 3, 2017 (82 FR 36150). 
The document was published with the incorrect docket number. This 
document corrects that error.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, Food 
and Drug Administration, Bldg. 32, Rm. 3330, Silver Spring, MD 20993-
0002, 301-796-9115.

SUPPLEMENTARY INFORMATION: In the Federal Register of Thursday, August 
3, 2017, in FR Doc. 2017-16377, on page 36150, the following correction 
is made:
    1. On page 36150, in the second column, in the header of the 
document, ``Docket No. FDA-2017-N-0002'' is corrected to read ``Docket 
No. FDA-2017-N-4642''.

    Dated: August 28, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-18813 Filed 9-5-17; 8:45 am]
 BILLING CODE 4164-01-P


